Business Wire

Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology ...
Yahoo Finance

Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments

WHITE PLAINS, N.Y., Feb. 17, 2026 /PRNewswire/ -- Retia Medical today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Argos Infinity™, the company's ...
Business Wire

Elixir Medical Completes Enrollment of INFINITY-SWEDEHEART Clinical Trial

MILPITAS, Calif.--(BUSINESS WIRE)--Elixir Medical, a developer of breakthrough cardiovascular technologies, today announced enrollment completion in INFINITY-SWEDEHEART, a prospective, multicenter, ...
Wall Street Journal

IMED Infinity Medical L.P.

1 Day IMED 0.00% DJIA 0.69% Russell 2K 0.61% Health Care/Life Sciences -0.21% ...
Morningstar

Imed Infinity Medical LP Ordinary Shares

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.